These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 24999797

  • 1. The effects of cognitive behavioral therapy in female nursing students with irritable bowel syndrome: a randomized trial.
    Jang AL, Hwang SK, Kim DU.
    Eur J Gastroenterol Hepatol; 2014 Aug; 26(8):918-26. PubMed ID: 24999797
    [Abstract] [Full Text] [Related]

  • 2. Changes in illness-related cognitions rather than distress mediate improvements in irritable bowel syndrome (IBS) symptoms and disability following a brief cognitive behavioural therapy intervention.
    Chilcot J, Moss-Morris R.
    Behav Res Ther; 2013 Oct; 51(10):690-5. PubMed ID: 23948131
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome.
    Boyce PM, Talley NJ, Balaam B, Koloski NA, Truman G.
    Am J Gastroenterol; 2003 Oct; 98(10):2209-18. PubMed ID: 14572570
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Predictors of treatment outcome after cognitive behavior therapy and antispasmodic treatment for patients with irritable bowel syndrome in primary care.
    Reme SE, Kennedy T, Jones R, Darnley S, Chalder T.
    J Psychosom Res; 2010 Apr; 68(4):385-8. PubMed ID: 20307706
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Internet-delivered exposure-based treatment vs. stress management for irritable bowel syndrome: a randomized trial.
    Ljótsson B, Hedman E, Andersson E, Hesser H, Lindfors P, Hursti T, Rydh S, Rück C, Lindefors N, Andersson G.
    Am J Gastroenterol; 2011 Aug; 106(8):1481-91. PubMed ID: 21537360
    [Abstract] [Full Text] [Related]

  • 9. Predictors of outcome in cognitive and behavioural interventions for irritable bowel syndrome. A meta-analysis.
    Radu M, Moldovan R, Pintea S, Băban A, Dumitrascu D.
    J Gastrointestin Liver Dis; 2018 Sep; 27(3):257-263. PubMed ID: 30240469
    [Abstract] [Full Text] [Related]

  • 10. Cognitive behavioural therapy in addition to antispasmodic therapy for irritable bowel syndrome in primary care: randomised controlled trial.
    Kennedy TM, Chalder T, McCrone P, Darnley S, Knapp M, Jones RH, Wessely S.
    Health Technol Assess; 2006 Jun; 10(19):iii-iv, ix-x, 1-67. PubMed ID: 16729918
    [Abstract] [Full Text] [Related]

  • 11. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
    Choi CH, Jo SY, Park HJ, Chang SK, Byeon JS, Myung SJ.
    J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358
    [Abstract] [Full Text] [Related]

  • 12. Provoking symptoms to relieve symptoms: a randomized controlled dismantling study of exposure therapy in irritable bowel syndrome.
    Ljótsson B, Hesser H, Andersson E, Lackner JM, El Alaoui S, Falk L, Aspvall K, Fransson J, Hammarlund K, Löfström A, Nowinski S, Lindfors P, Hedman E.
    Behav Res Ther; 2014 Apr; 55():27-39. PubMed ID: 24584055
    [Abstract] [Full Text] [Related]

  • 13. Patients' Experiences of Telephone-Based and Web-Based Cognitive Behavioral Therapy for Irritable Bowel Syndrome: Longitudinal Qualitative Study.
    Hughes S, Sibelli A, Everitt HA, Moss-Morris R, Chalder T, Harvey JM, Vas Falcao A, Landau S, O'Reilly G, Windgassen S, Holland R, Little P, McCrone P, Goldsmith K, Coleman N, Logan R, Bishop FL.
    J Med Internet Res; 2020 Nov 20; 22(11):e18691. PubMed ID: 33216002
    [Abstract] [Full Text] [Related]

  • 14. Cognitive behavioural therapy for irritable bowel syndrome: 24-month follow-up of participants in the ACTIB randomised trial.
    Everitt HA, Landau S, O'Reilly G, Sibelli A, Hughes S, Windgassen S, Holland R, Little P, McCrone P, Bishop FL, Goldsmith K, Coleman N, Logan R, Chalder T, Moss-Morris R.
    Lancet Gastroenterol Hepatol; 2019 Nov 20; 4(11):863-872. PubMed ID: 31492643
    [Abstract] [Full Text] [Related]

  • 15. Mediators of change in cognitive behaviour therapy and mebeverine for irritable bowel syndrome.
    Reme SE, Stahl D, Kennedy T, Jones R, Darnley S, Chalder T.
    Psychol Med; 2011 Dec 20; 41(12):2669-79. PubMed ID: 21477419
    [Abstract] [Full Text] [Related]

  • 16. Cognitive behavioral therapy for irritable bowel syndrome: the effects on state and trait anxiety and the autonomic nervous system during induced rectal distensions - An uncontrolled trial.
    Edebol-Carlman H, Schrooten M, Ljótsson B, Boersma K, Linton S, Brummer RJ.
    Scand J Pain; 2018 Jan 26; 18(1):81-91. PubMed ID: 29794287
    [Abstract] [Full Text] [Related]

  • 17. A pilot feasibility study of an unguided, internet-delivered cognitive behavioral therapy program for irritable bowel syndrome.
    Owusu JT, Sibelli A, Moss-Morris R, van Tilburg MAL, Levy RL, Oser M.
    Neurogastroenterol Motil; 2021 Nov 26; 33(11):e14108. PubMed ID: 33745228
    [Abstract] [Full Text] [Related]

  • 18. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar 26; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 19. Improvement in Gastrointestinal Symptoms After Cognitive Behavior Therapy for Refractory Irritable Bowel Syndrome.
    Lackner JM, Jaccard J, Keefer L, Brenner DM, Firth RS, Gudleski GD, Hamilton FA, Katz LA, Krasner SS, Ma CX, Radziwon CD, Sitrin MD.
    Gastroenterology; 2018 Jul 26; 155(1):47-57. PubMed ID: 29702118
    [Abstract] [Full Text] [Related]

  • 20. Self-administered cognitive behavior therapy for moderate to severe irritable bowel syndrome: clinical efficacy, tolerability, feasibility.
    Lackner JM, Jaccard J, Krasner SS, Katz LA, Gudleski GD, Holroyd K.
    Clin Gastroenterol Hepatol; 2008 Aug 26; 6(8):899-906. PubMed ID: 18524691
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.